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COMMITTEE’S TASK AND OVERARCHING ISSUES 
 
To review the seven NASA evidence reports, the IOM assembled a 
14-member committee with expertise in aerospace medicine, occupation-
al health, radiation medicine, human performance, internal medicine, 
physiology and exercise science, respiratory health, behavioral health, food 
sciences and nutrition, human factors engineering, materials sciences, and 
biomedical informatics. Committee biographical sketches are included in 
Appendix B.  
The committee’s task, detailed in Box 1, was to review each evi-
dence report in response to nine specific questions. In summary, this re-
port examines the quality of the evidence, analysis, and overall 
construction of each report; identifies existing gaps in report content; and 
provides suggestions for additional sources of expert input. This report 
also builds on the 2008 IOM report Review of NASA’s Human Research 
Program Evidence Books: A Letter Report, which assessed the process 
for developing NASA’s evidence reports and provided an initial and 
brief review of NASA’s original evidence report.1  
The committee approached its task by analyzing each evidence re-
port’s overall quality, which included readability; internal consistency; 
the source and breadth of cited evidence; identification of existing 
knowledge and research gaps; authorship expertise; and, if applicable, 
response to recommendations from the IOM letter report previously 
described. 
 It is difficult to characterize and compare the quality of evidence cit-
ed in individual evidence reports. In the 2008 letter report, the IOM 
urged NASA to “require authors to use categories of evidence in future 
versions of the evidence books, while recognizing that experience with 
the explicit categorization of evidence may be refined over time, particu-
larly regarding the categories used” (IOM, 2008, p. 12). NASA encour-
ages evidence report authors “to label evidence according to the ‘NASA 
Categories of Evidence’” (NASA, 2013a).2 Authors of NASA evidence 
reports should be encouraged to adhere to standard guidelines for sys-
tematic reviews (Huguet et al., 2013; IOM, 2011; Wallace et al., 2013). 
                                                     
1The original evidence book was “a collection of evidence reports created from the in-
formation presented verbally and discussed within the NASA HRP [Human Research 
Program] in 2006” (NASA, 2013a).  
2NASA has identified three categories of evidence that could be included in each evi-
dence report, including data from controlled experiments, observational studies, and ex-
pert opinion (NASA, 2013a).  
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Furthermore, as noted in prior IOM letter reports (IOM, 2014, 2015), 
substantial variability exists in the formatting, internal consistency, and 
completeness of the references among individual evidence reports, mak-
ing it difficult to compare cited evidence for related human health risks. 
NASA is encouraged to select a preferred citation format for all evidence 
reports and to require all writing teams to use that format.  
 
 
BOX 1 
Review of NASA’s Evidence Reports on Human Health Risks 
Statement of Task 
 
NASA has requested a study from the Institute of Medicine (IOM) to 
provide an independent review of more than 30 evidence reports on human 
health risks for long duration and exploration spaceflight. The evidence 
reports, which are publicly available, are categorized into five broad cate-
gories: (1) behavioral health and performance; (2) human health counter-
measures (with a focus on bone metabolism and orthopedics, nutrition, 
immunology, and cardiac and pulmonary physiology); (3) radiation; (4) 
human factors issues; and (5) exploration medical capabilities. The reports 
are revised on an ongoing basis to incorporate new scientific information. 
In conducting this study, an IOM ad hoc committee will build on the 
2008 IOM report Review of NASA’s Human Research Program Evidence 
Books. That report provided an assessment of the process used for devel-
oping the evidence reports and provided an initial review of the evidence 
reports that had been completed at that time. 
Each year, NASA staff will identify a set of evidence reports for com-
mittee review. Over the course of the study all evidence reports will be 
reviewed. The committee will hold an annual scientific workshop to re-
ceive input on the evidence reports it is reviewing that year and an update 
on the recent literature. The committee will issue an annual letter report 
that addresses the following questions relevant to each evidence report: 
 
1. Does the evidence report provide sufficient evidence, as well as 
sufficient risk context, that the risk is of concern for long-term 
space missions? 
2. Does the evidence report make the case for the research gaps 
presented? 
3. Are there any additional gaps in knowledge or areas of fundamen-
tal research that should be considered to enhance the basic under-
standing of this specific risk? 
4. Does the evidence report address relevant interactions among risks? 
5. Is input from additional disciplines needed? 
6. Is the breadth of the cited literature sufficient? 
4 REVIEW OF NASA’S EVIDENCE REPORTS ON HUMAN HEALTH RISKS  
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7. What is the overall readability and quality? 
8. Is the expertise of the authors sufficient to fully cover the scope of 
the given risk? 
9. Has the evidence report addressed previous recommendations 
made by the IOM in the 2008 letter report? 
 
 
In addition to analyzing the content of individual letter reports, the 
committee also gathered evidence from existing literature and relevant 
experts in the field. The committee held two conference call meetings 
and one in-person meeting, with the latter held in conjunction with a 
public workshop (see Appendix A). At the workshop, the committee in-
vited individuals with expertise related to at least one of the seven evi-
dence reports to analyze NASA’s evidence reports and engage in 
discussions with the committee, focusing on the following questions: 
 
• How well is the risk understood? 
• What, if any, are the major sources of disagreement in the litera-
ture pertaining to this risk? 
• What are the main gaps in knowledge or fundamental research 
about the risk? 
• What is known about interactions between the risk and other 
risks identified in NASA’s evidence reports? 
 
This report follows the format of the prior IOM letter reports, which 
includes the committee’s responses to each of the questions listed in its 
statement of task for each of the seven evidence reports. Although no 
formal recommendations are included in this report, the committee’s ob-
servations are intended to inform and improve NASA’s ongoing efforts 
to update the content of individual evidence reports. 
 
 
THE NASA HUMAN RESEARCH ROADMAP 
  
 The evidence reports reviewed in this IOM report are part of a larger 
roadmap process developed and under implementation by NASA’s Hu-
man Research Program (HRP). The goals of the HRP are to “provide 
human health and performance countermeasures, knowledge, technolo-
gies, and tools to enable safe, reliable, and productive human space ex-
ploration” (NASA, 2014a). As outlined in Figure 1, the evidence reports 
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and documents the wealth of data that have been obtained through prior 
spaceflights as well as through human ground-based studies and animal 
experiments. As noted in the evidence report, it has become apparent that 
as mission duration progresses, skeletal muscle health and performance 
deficits occur. These skeletal muscle deficits pose potentially serious risk 
to crewmembers on multiple levels. In addition to documenting the risk, 
the evidence report also highlights historical and current perspectives of 
exercise countermeasure development, the evolution of exercise hard-
ware, and the complexities associated with minimizing the reductions in 
skeletal muscle mass and resulting decrements in function with space-
flight. The authors rely on the scientific literature and NASA technical 
reports to provide a comprehensive document. The committee’s respons-
es to the key review questions are summarized below. 
 
Does the Evidence Report Provide Sufficient Evidence,  
as Well as Sufficient Risk Context, That the Risk Is of Concern  
for Long-Term Space Missions? 
 
 The evidence report provides an excellent summary of manned 
spaceflight from the early missions to current 6-month stays on the ISS. 
Numerous aspects of skeletal muscle health and its intersection with ex-
ercise programs and hardware (i.e., exercise devices) are presented. 
Likewise, animal data and myocellular findings related to the mechanis-
tic aspect of skeletal muscle in microgravity are also presented. Several 
knowledge gaps are identified, and numerous suggestions for future re-
search are presented. 
 The report would be improved by providing a more detailed descrip-
tion of the exercise dosing/titration models used to mitigate skeletal mus-
cle loss with microgravity. As highlighted by the author team, there has 
been excellent progress in the countermeasure program for skeletal mus-
cle in the past 20 years from ground analogs including bed rest and ani-
mal studies using unilateral lower-limb suspension to space shuttle and 
ISS observations that clearly show that high-intensity exercise is benefi-
cial. However, details on the exercise protocol progression (sets, reps, 
timing, and dosing of aerobic, anaerobic, and resistance exercise) should 
be more thoroughly profiled to help guide the exercise prescription into 
the future. 
 
2015 LETTER REPORT 7 
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Does the Evidence Report Make the Case for the  
Research Gaps Presented? 
 
 Several gaps are identified with excellent justification from relevant 
tasks for successful and safe space travel with varied mission objectives. 
Furthermore, scientifically based evidence is presented where appropriate 
to further highlight the potential health risks associated with spaceflight. 
 Figure 11 in the evidence report (Figure 2 below) highlights the large 
individual variability in muscle strength changes with long-duration stays 
on the ISS and stands out as an example of the challenges with skeletal 
muscle health with spaceflight. Interestingly, the variability presented is 
well outside the range observed in numerous human ground-based ana-
log studies (i.e., bed rest). This is most likely a result of varied approach-
es to the exercise program, hardware, preflight fitness levels of the crew, 
as well as other confounding factors of working in space and the geno-
typic and phenotypic variability between crewmembers. 
 
 
 
FIGURE 2 Post-flight changes (percent change) in isokinetic leg and trunk 
strength for long-duration ISS crewmembers using iRED (interim Resistive Ex-
ercise Device) and ARED (Advanced Resistive Exercise Device) during their 
flight.  
NOTE: KE = knee extensor, KF = knee flexor, PF (not defined).  
SOURCE: Ploutz-Snyder et al., 2015. 
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Are There Any Additional Gaps in Knowledge  
or Areas of Fundamental Research That Should Be Considered  
to Enhance the Basic Understanding of This Specific Risk? 
 
Additional knowledge gaps that relate to the skeletal muscle health 
challenges associated with long-duration space travel could be added, 
including 
 
• Further define skeletal muscle-specific tasks and the perfor-
mance parameters (muscle groups used, strength, power, and du-
ration) necessary to perform these tasks. This is paramount for 
understanding the muscle performance necessary to execute mis-
sion specific objectives and emergency contingencies. This needs 
to be defined both for steady-state spaceflight experiences and for 
transition states to other planets. Understanding the task require-
ments is critical to defining minimum fitness for duty standards, 
which also serve as a measure of countermeasure efficacy.  
• Further research is needed to identify the proper balance of aero-
bic and resistance exercise best suited to protect skeletal muscle 
health during spaceflight, especially in light of Figure 11 of the 
evidence report that shows the extensive differences in individu-
al variability. To date, the exercise prescription remains incom-
plete, and more scientific data at the whole body and cell level 
are needed to further elucidate the best exercise paradigm. Skele-
tal muscle biology is complex with varied integrated responses 
in the minutes, hours, and days following an exercise stimulus. 
The muscle biology response also varies depending upon the ex-
ercise mode (aerobic versus. resistance) and the timing relative 
to successive exercise bouts. These concepts need to be more 
thoroughly understood in order to develop a complete exercise 
countermeasure for skeletal muscle health that will likely affect 
other physiological and organ systems. Further, human physiol-
ogy and the response to exercise vary based on genotype, so 
countermeasures may need to be varied on an individual basis.  
• A practical method is needed to monitor, at the individual astro-
naut level, performance characteristics of important muscle 
groups and could include muscle imaging (for size and thick-
ness). This will help guide individual exercise prescriptions dur-
ing adaption to microgravity. 
2015 LETTER REPORT 9 
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• Breaks from exercise and variation in the exercise regimen 
(termed periodization) are likely to be required during a long-
duration mission to Mars. Breaks may also be required during 
recovery from injury or to prevent overtraining, and rehabilita-
tion plans are needed to account for time off from the exercise-
training program that may occur from injury or illness. Little is 
known about periodic time off during the training routine in a 
microgravity environment and how this will affect skeletal mus-
cle health and other physiological systems. 
• The nutritional interface with skeletal muscle adaptation needs 
attention and could provide new strategic opportunities to en-
hance the skeletal muscle response to exercise. It is likely that 
the timing (before, during, and after exercise) of carbohydrate 
and protein intake could positively enhance the biological re-
sponse to exercise in the space environment. Numerous exam-
ples in the sport science literature support this concept and could 
be used as initial guidance. However, more work on the unique 
interface of skeletal muscle in a microgravity environment (real 
and simulated) with exercise and nutrition is an area that war-
rants further exploration and could be a crosscutting platform 
with various metabolic aspects of skeletal muscle (i.e., substrate 
flux, microcirculation/blood flow) to enhance/impact the exer-
cise program. 
• The discussion on hormone interaction with skeletal muscle 
should be expanded beyond insulin. There are likely key regula-
tory aspects of cortisol, androgens, estrogen, and myokines that 
would affect the net protein balance of skeletal muscle. Evidence 
is emerging that skeletal muscle acts as a secretory organ, with 
myokines being responsive to exercise and mediators of inflam-
mation, as well as evidence of crosstalk with other organ systems 
(Pedersen and Febbraio, 2012; Pratesi et al., 2013). Circadian 
rhythm(s) and their influence on hormonal balance and muscle 
physiology and performance should be further explored. As a re-
sult, this area has the potential to impact health beyond skeletal 
muscle and would be crosscutting for other biological systems 
(i.e., systems biology). 
• The effect of pharmaceuticals on muscle biology and exercise 
response warrants investigation. Both over-the-counter (i.e., non-
steroidal anti-inflammatory drugs) and prescription (i.e., statins) 
are known to impact muscle physiology and exercise response 
10 REVIEW OF NASA’S EVIDENCE REPORTS ON HUMAN HEALTH RISKS  
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(Trappe et al., 2002, 2011). Various medications used during a 
mission could potentially interact with skeletal muscle biology in 
such a way as to influence the anabolic and catabolic state of the 
muscle and the subsequent response to exercise.  
• Attention to potential sex differences in skeletal muscle adapta-
tion to microgravity and the response to exercise needs to be 
strongly considered. This was recommended in the 2008 IOM 
report and does not appear to have been addressed. Growing evi-
dence in the literature shows that sex differences are apparent in 
the biological response to exercise and various populations 
groups (i.e., aging) (Hunter, 2014; Ploutz-Snyder et al., 2014). 
• Impact of preflight fitness and training status on the rate and ex-
tent of muscle function loss is important to define, especially as 
it relates to countermeasure development. Moreover, preflight 
fitness and training status intersect with task-specific demands 
and physiological reserve, which may be critical in gravitational 
transition states and emergency situations. 
 
Does the Evidence Report Address Relevant Interactions  
Among Risks? 
 
The report does an excellent job discussing the interactions among 
the risks listed in the evidence report. However, as highlighted above, 
additional interactions with skeletal muscle related to nutrition, hor-
mones/myokines, pharmacokinetics, disrupted circadian rhythms, sex, 
and defining minimum muscle strength and power requirements for mis-
sion tasks (e.g., EVAs) should be explored and discussions of potential 
interactions should be added to the relevant evidence reports. The com-
mittee also noted the potential impact of exercise devices on various 
physiological systems (i.e., integrative biology). In particular, the poten-
tial influence of the relatively new Advanced Resistance Exercise Device 
(ARED) on intraocular pressure is of recent research interest (IOM, 
2014). The committee expressed interest in energy balance as it relates to 
exercise (i.e., oxygen consumption), nutrient intake, and storage of 
enough food supplies to support a mission. Lastly, exercise as a mood 
enhancer during extended space missions was discussed and would be 
interactive with various psychological parameters. 
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What Is the Overall Readability and Quality? 
 
The report was well written and organized to provide a high-quality 
document that was easy to follow and comprehend.  
 
Is the Breadth of the Cited Literature Sufficient? 
 
For the topics directly covered in this report the cited references were 
comprehensive. However, it is likely the narrative and supporting refer-
ences will need to be expanded to adequately address the newly identi-
fied knowledge gaps. 
 
Is the Expertise of the Authors Sufficient to Fully Cover 
the Scope of the Given Risk? 
Is Input from Additional Disciplines Needed? 
 
The expertise of the author team is excellent, although additional 
perspectives may be beneficial to expand the knowledge to include other 
disciplines that are emerging (i.e., myokines) or intersect with other 
physiological systems (i.e., nutrition) that will address the additional 
knowledge gaps identified. 
There are several emerging areas resulting in additional knowledge 
gaps involving skeletal muscle health that intersect with other disciplines 
(i.e., nutrition, microcirculation, hormone biology, drug interactions) that 
will most likely require additional input from experts in these areas for 
future iterations of the evidence report. These crosscutting areas further 
highlight the complex and integrated nature of these systems. 
 
Has the Evidence Report Addressed Previous Recommendations  
Made by the IOM in the 2008 Letter Report? 
 
The evidence report addressed several of the recommendations of the 
previous report to provide a more comprehensive discussion related to 
human control subjects and a more detailed overview of the progression 
in exercise countermeasures over the past 50 years. The 2008 report rec-
ommended that sex-related issues for skeletal muscle health be discussed 
in the context of spaceflight. However, this is still lacking in the current 
evidence report. Partially addressed is the effectiveness of various exer-
cise modalities. This was primarily due to the limited published data 
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available in this area, and it is recommended that this continue to evolve 
with subsequent reports. 
 
 
RISK OF REDUCED PHYSICAL PERFORMANCE 
CAPABILITIES DUE TO REDUCED AEROBIC CAPACITY 
 
A solid base of evidence is available on the nature of the aerobic de-
conditioning that occurs with spaceflight, as well as on the physiological 
mechanisms that underpin this deconditioning, ground-based analogs of 
reduced gravity and exercise countermeasures (e.g., Convertino et al., 
2010; Lee et al., 2010). Evidence has also been published on the interac-
tions between these factors and thermoregulation and orthostatic intoler-
ance (Guinet et al., 2009; Mekjavic et al., 2012). Additionally, much of 
this evidence can be framed in the context of routine performance de-
mands in space and also more extreme challenges such as EVAs. The 
evidence report Risk of Reduced Physical Performance Capabilities Due 
to Reduced Aerobic Capacity (Downs et al., 2015) provides an overview 
highlighting historical and current perspectives on exercise countermeas-
ure development. The report draws primarily on observational and exper-
imental data collected during and after spaceflight along with human 
ground-based analog studies (i.e., bed rest). The authors rely on the sci-
entific literature and NASA technical reports to provide a comprehensive 
document. The committee’s responses to the key review questions are 
summarized below. 
 
Does the Evidence Report Provide Sufficient Evidence,  
as Well as Sufficient Risk Context, That the Risk Is of Concern  
for Long-Term Space Missions? 
 
The evidence report provides an excellent summary of issues related 
to maintenance of maximal aerobic capacity during manned spaceflights 
from the early missions to current 6-month stays on the ISS. However, 
aerobic capacity (VO2 max), while often used as a metric of maximal 
exercise ability, does not closely reflect the capacity to perform a sub-
maximal task, particularly if effort is required for more than a short time. 
Therefore, this evidence report needs to be focused more directly on the 
development, maintenance, and mitigation of task-specific physiological 
capacity before and during any envisioned mission. The report is focused 
largely on changes in VO2 max or peak work capacity, how it is affected 
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by spaceflight duration, and how these changes are affected by individual 
differences in astronauts. For example, the report describes the effects of 
baseline fitness and the role of exercise intensity as potential modifiers of 
the fall in VO2 max during spaceflight. The key roles of changes in 
stroke volume and plasma/blood volume are highlighted throughout the 
report. Several knowledge gaps are identified and numerous suggestions 
for future research presented.  
The report would be strengthened by providing additional infor-
mation on arm-specific aerobic exercise capacity in response to space-
flight and/or bed rest. The rationale is that certain high stress EVA tasks 
have a major upper-body component. 
Given the work on intense aerobic training followed by reduced 
training intensity, frequency, or duration published primarily during the 
1980s, the committee found it surprising that more information on relat-
ed topics is not available (e.g., Hickson et al., 1982, 1984, 1985). To the 
extent that information is available on these topics it should be added to 
the evidence report. 
 
Does the Evidence Report Make the Case for the  
Research Gaps Presented? 
 
Several gaps were identified with excellent justification from relevant 
tasks for successful and safe space travel with varied mission objectives. 
Furthermore, scientifically based evidence was presented to further high-
light the potential health risks associated with spaceflight. Several of the 
gaps focused on the need to better understand the peak aerobic physio-
logical stresses (intensity and duration) on crews and how fitness stand-
ards and interventions could be most efficiently designed to meet these 
potential stresses. However, these stressors are likely to have at least 
some intermittent exercise elements and also require muscular strength 
and coordination. This information should be integrated with the Muscle 
Mass evidence report (Ploutz-Snyder et al., 2015) discussed above so a 
comprehensive strategy can be developed. The need to integrate the 
physiology with exercise hardware is also key, especially if there is to be 
greater focus on upper-body aerobic performance. 
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Are There Any Additional Gaps in Knowledge or Areas 
of Fundamental Research That Should Be Considered to Enhance 
the Basic Understanding of This Specific Risk? 
 
 The knowledge gaps presented at the end of the report are compre-
hensive. The following areas are highlighted as areas where additional 
emphasis might be useful: 
 
• Further define tasks and the aerobic capabilities necessary to per-
form these tasks for spaceflight experiences and transition states 
to other planets. This is paramount for understanding the physio-
logical capacity necessary to execute mission-specific objectives 
and emergency contingencies. 
• Improved understanding of upper-body aerobic capacity and re-
lated countermeasures, because many tasks require substantial 
upper-body efforts. 
• Expanding the evidence base for the concept that occasional 
minimal-duration, high-intensity exercise bouts might be highly 
protective against declines in VO2 max and also reduce the need 
for prolonged exercise training sessions. 
• Better understanding of emerging evidence about blood-flow-
restricted exercise as a way to increase the efficacy of the exer-
cise training stimulus. 
• The potential usefulness of occasional training with intentional 
thermal stress to both increase plasma volume and maintain aer-
obic capacity. 
• The need to integrate the aerobic exercise countermeasure stand-
ards with: 
o Skeletal muscle standards  
o Nutrition planning relevant to voluntary exercise and food 
needs. Such planning should include both the minimal exer-
cise needed to maintain fitness, and some additional “volun-
tary” exercise for recreation and for mood elevation. 
o Integration of the fitness standards with performance re-
quirements and consideration of these requirements in the 
context of technology or other ergonomic approaches that 
might limit these demands.  
• The exploitation of inter-individual physiological capacity to 
match individual crewmember physiology to the tasks they are 
assigned. 
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 In agreement with the Muscle Mass report (Ploutz-Snyder et al., 
2015) described above, there is a need to emphasize the following issues: 
 
• The exercise dose–response relationship needs further research 
to identify the proper balance of aerobic and resistance exercise 
best suited to protect both aerobic capacity and skeletal muscle 
health during spaceflight. To date, the exercise prescription 
remains incomplete and more scientific data at the whole body and 
cell level are needed to further elucidate the best exercise paradigm.  
• A simple way to monitor individual astronaut aerobic as well as 
skeletal muscle strength during mission needs to be developed. 
In a manner similar to that described for the previous report, this 
would allow modification of the individual exercise prescription 
as needed. 
• Improved understanding is needed of the effect of nutritional in-
take and its timing relative to exercise on the physiological re-
sponse to exercise.  
• Preflight fitness and training status, including upper-body exer-
cise capacity, should be addressed as these variables have the 
likelihood to affect the adaptive response microgravity and sub-
sequent countermeasures to combat the loss of aerobic capacity. 
Moreover, pre-flight fitness and training status intersect with task-
specific demands and physiological reserve, which may be critical 
in gravitational transition states and emergency situations. 
 
Does the Evidence Report Address Relevant Interactions 
Among Risks? 
 
The report does an excellent job discussing the interactions among 
the risks listed in the evidence report, in particular the interactions be-
tween aerobic deconditioning and orthostatic intolerance. Discussion of 
interactions with the performance issues raised in the EVA evidence re-
port (Chappell et al., 2015) could be added.  
 
What Is the Overall Readability and Quality? 
 
The report was well written and organized to provide a high-quality 
document that was easy to follow and comprehend.  
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Is the Breadth of the Cited Literature Sufficient? 
 
For the topics directly covered in this report the cited references were 
comprehensive. However, it is likely the narrative and supporting refer-
ences will need to be expanded to adequately address the newly identi-
fied knowledge gaps. Key areas to consider include older and more 
recent data on short-duration, high-intensity intervals as a way to protect 
aerobic capacity and also emerging ideas about blood flow restriction dur-
ing training as a method to enhance peripheral adaptations to exercise. 
 
Is the Expertise of the Authors Sufficient to Fully Cover 
the Scope of the Given Risk? 
Is Input from Additional Disciplines Needed? 
  
The expertise of the author team is quite good, although additional 
perspectives as outlined above might be helpful. There are several 
emerging areas resulting in additional knowledge gaps. As noted above, 
the aerobic exercise standards, performance demands, and training inter-
ventions need ongoing integration with the skeletal muscle and nutrition 
evidence base. All of these need to be integrated with the physiological 
demands of anticipated and emergency tasks. They also need to be inte-
grated with many logistical and ergonomic issues from areas such as nu-
trition, sleep, suit design, and psychology.  
 
Has the Evidence Report Addressed Previous Recommendations  
Made by the IOM in the 2008 Letter Report? 
 
 The evidence report addressed several of the recommendations of the 
previous report to provide a more comprehensive discussion related to 
human control subjects and a more detailed overview of the progression 
in exercise countermeasures over the past 50 years. The 2008 report 
recommended: 
 
The gaps should include preflight fitness requirements for cardiovas-
cular capacity relating to prolonged space travel. Gender should also 
be considered as a potential gap. Although gender-related data are 
limited, it does point to a potential issue. Gaps 4 and 6 should in-
clude cardiac and skeletal muscle mass as potentially important con-
tributors to cardiovascular performance. (p. 55)  
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As noted above, gaps identical to or directly related to this gap from 
2008 persist. 
 
 
RISK OF ORTHOSTATIC INTOLERANCE DURING  
RE-EXPOSURE TO GRAVITY 
 
The problem of orthostatic intolerance—an inability to adequately 
regulate blood pressure after spaceflight when body posture is aligned 
with a substantial positive gravity gradient—has been recognized since 
the final Mercury mission (34-hours duration). The evidence report Risk 
of Orthostatic Intolerance During Re-Exposure to Gravity (Stenger et al., 
2015) provides an overview of the solid base of evidence that exists on 
the nature of the problem including documenting the relevant experienc-
es from the Shuttle, Mir, and ISS eras. On Earth, orthostatic hypotension 
can have many causes. It affects approximately 5 percent of patients un-
der 50 years of age, increasing as a function of age to 30 percent of those 
over 70 years of age (Ricci et al., 2015). Similarly, there is a good under-
standing of the physiological mechanisms that underpin it and the inter-
actions with other stresses, including thermal stress, nutrition/hydration, 
and physical (in)activity.  
Orthostatic intolerance is not as much a problem during the orbital or 
cruise phases of spaceflight as it is during launch, landing, and egress 
(Stenger et al., 2015). However, it should be noted that orthostatic intol-
erance is most predictably evoked by quiescent standing without en-
gagement of the muscle pump at times of changing from less to more 
gravitational stress. Orthostatic intolerance is thus unlikely to occur dur-
ing sustained microgravity; after adjustment (perhaps hours to days) to a 
new gravitational field greater than that to which the astronaut has been 
exposed; and during the transient phase of landing and spacecraft egress 
after flight, when active muscular effort is usually required (Stenger et 
al., 2015).  
This evidence report draws on observational and experimental data 
collected during and after spaceflight along with human ground-based 
analog studies (e.g., hypovolemia and bed rest). The authors rely on the 
scientific literature and NASA technical reports to provide an evidence 
report that is comprehensive and well written.  
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Does the Evidence Report Provide Sufficient Evidence,  
as Well as Sufficient Risk Context, That the Risk Is of Concern  
for Long-Term Space Missions? 
 
The evidence report summarizes the incidence of orthostatic intoler-
ance well, highlighting the observation that the incidence of orthostatic 
intolerance is directly related to the duration of exposure to microgravity 
during spaceflight. The evidence report posits sex-specific differences 
in orthostatic intolerance. As further discussed below, a critical gap iden-
tified in the evidence report concerns the unknowns regarding how 
exploration-duration flights (greater than 1 year) will affect orthostatic 
intolerance and cardiovascular regulation. Whether extremely long voy-
ages, such as to Mars, increase the risk after landing on a planet with 
substantially less gravity than on Earth is of course unknown. The evi-
dence report also makes the case that orthostatic intolerance recovers 
rapidly following return to 1G, but there is a fundamental lack of evi-
dence regarding landing in or return from fractional G environments. The 
evidence report provides an extensive discussion of the multifactorial eti-
ology of orthostatic intolerance, including fluid redistribution, hypovole-
mia, cardiac/vascular atrophy, and autonomic dysregulation. Each of these 
factors can induce orthostatic intolerance.  
 
Does the Evidence Report Make the Case for the  
Research Gaps Presented? 
 
The evidence report provides a substantive review of the mecha-
nisms that contribute to orthostatic intolerance. The gaps focus appropri-
ately on orthostatic intolerance in lunar and Mars gravitational fields, 
which can be mimicked using head-up tilt at approximately +10° and 
+22°, respectively. It is not known if these gradients are sufficient to 
evoke orthostatic intolerance, and further, if prolonged exposure to par-
tial gravity environments will evoke intolerance when shorter exposures 
would not. 
A considerable section of the evidence report reviews modeling ap-
proaches to predict susceptibility to orthostatic intolerance. Several dy-
namic models are reviewed, which can be used to simulate compensatory 
responses to standing and changes comparable to short-term exposures to 
a free fall environment. The evidence report authors appropriately de-
scribe a lack of rigorous verification, validation, and uncertain quantifi-
2015 LETTER REPORT 19 
 
PREPUBLICATION COPY: UNCORRECTED PROOFS 
cation procedures for these models. Structural equation modeling has 
provided some utility and could help fill this gap (Wallace et al., 2010).  
The evidence report includes a thorough discussion of potential 
countermeasures to ameliorate orthostatic intolerance. Five categories of 
countermeasures are featured: fluid loading, artificial gravity, lower-
body negative pressure during microgravity, pharmacotherapy, and com-
pression garments during transition stages. Overall, this section is well 
organized and the literature cited in each area is appropriate, including a 
mix of fundamental and operational research.  
 
Are There Any Additional Gaps in Knowledge or Areas 
of Fundamental Research That Should Be Considered to Enhance 
the Basic Understanding of This Specific Risk? 
 
The committee has identified additional areas to be considered in fu-
ture iterations of this evidence report: 
 
• Fractional gravity is addressed appropriately, but available data 
are relatively incomplete. The orthostatic stress imposed by lunar 
or Martian gravity could be sufficiently large to constitute a risk 
when transitioning from prolonged flights in zero-G gravity. 
Alternatively, in expedition-class missions chronic exposure to 
these fields could have a protective effect against cardiovascular 
deconditioning.  
• Orthostatic intolerance can be evoked in any human being if the 
imposed orthostatic stress is of sufficient magnitude and dura-
tion. The extent to which this affects operational capabilities has 
not been established. The evidence report provides no reports of 
orthostatic events during ascent or re-entry phases of spaceflight. 
• There is a well-established interaction between thermal stress 
and orthostatic intolerance, associated with a displacement of a 
portion of circulating blood volume to the compliant cutaneous 
vascular bed. This interaction could occur during launch and en-
try if suit cooling is inadequate.  
• Individual susceptibility to and variability in severity of orthos-
tatic intolerance are not well defined.  
• Adrenergic receptor biology and excitation–contraction coupling 
in vascular smooth muscle have not been included in the review. 
Both hind-limb suspension models and spaceflight have revealed 
substantial changes that could impair sympathetic transduction—
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the coupling of sympathetic activity to a vascular smooth muscle 
response. Several coupled elements determine the response, in-
cluding norepinephrine release in response to depolarization; 
sensitivity to released norepinephrine; activation of adrenergic 
signaling cascades; and smooth muscle contraction. A number of 
countermeasures to improve orthostatic intolerance are discussed 
in the review but their comparative effectiveness needs to be 
analyzed.   
• The efficacy of combination countermeasure treatment is not 
particularly well developed, which is reflective of the state of the 
literature at this point in time. 
• Paradoxically, acute, high-intensity exercise appears to improve 
orthostatic intolerance, while prolonged exercise decreases it. 
Understanding the interaction with exercise could be modeled 
theoretically and tested experimentally. 
 
Does the Evidence Report Address Relevant Interactions  
Among Risks? 
 
To a limited extent, the evidence report considers interactions. 
The three areas most in need of additional work include thermal, ves-
tibular, and pharmacologic interactions. The risk mitigation plan for 
orthostatic intolerance is relatively advanced. However, the efficacy of 
combination therapies is a gap that should be addressed systematically. 
This evidence report describes unanticipated drug interactions 
resulting from combinations of pharmacological interventions that 
would not routinely be used in terrestrial medicine (for example, 
akathisia with combined use of midodrine and promethazine). The 
observation highlights the need to consider countermeasures individ-
ually and in the overall context of a treatment plan. 
 
What Is the Overall Readability and Quality? 
 
In general, the evidence report was well organized. The writing 
is complete. The document is easy to follow and comprehend. How-
ever, there are several mislabeled legends and figures. The color 
codes are reversed for Figure 16. 
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Is the Breadth of the Cited Literature Sufficient? 
 
For the topics directly covered in this evidence report the cited refer-
ences were comprehensive. However, it is likely the narrative and sup-
porting references will need to be expanded to adequately address the 
newly identified knowledge gaps, particularly in the areas of vascular 
biology and in dynamic monitoring and prediction of impending orthos-
tatic events (e.g., Behnke et al., 2011; Reisner et al., 2011; Stabley et al., 
2012; Taylor et al., 2013).  
 
Is the Expertise of the Authors Sufficient to Fully Cover 
the Scope of the Given Risk? 
Is Input from Additional Disciplines Needed? 
 
The expertise of the authoring team is appropriate. The cardiovascu-
lar descriptions are logical and thorough. Related disciplines that could 
provide additional insight include pharmacology, vascular biology, sta-
tistical validation of modeling techniques, and comparative effectiveness 
of countermeasures. These interventions need ongoing integration with 
the skeletal muscle and nutrition evidence base. All of these need to be 
integrated with the quantification of physiological demands of nominal 
and emergency tasks.  
 
Has the Evidence Report Addressed Previous Recommendations  
Made by the IOM in the 2008 Letter Report? 
 
The 2008 report identified the following recommendations: 
 
A particular concern is the total lack of information about 
whether partial-gravity exposure (1/6 G on the Moon and 3/8 G 
on Mars) will exacerbate or mitigate effects against orthostatic 
intolerance following prolonged spaceflight. Ground-based stud-
ies directed toward answering these questions are underway, but 
it is not clear that these can fully reproduce the effects of pro-
longed exposure to microgravity in space. To date, an effective 
countermeasure for orthostatic intolerance has not been fully 
identified. (p. 54) 
 
The gaps should include preflight fitness requirements for cardi-
ovascular capacity relating to prolonged space travel. Gender 
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should also be considered as a potential gap. Although gender-
related data are limited, it does point to a potential issue. Gaps … 
should include cardiac and skeletal muscle mass as potentially 
important contributors to cardiovascular performance. (p. 55) 
 
Clearly, the evidence base has expanded since the previous review of 
this area, and the authors should be commended for their regular update 
of this evidence report. However, as noted above, the fractional gravity 
area remains a research gap, and the information on exposure durations 
that inform exploration-class spaceflight risks are also still lacking.  
 
 
RISK OF INJURY AND COMPROMISED PERFORMANCE 
DUE TO EVA OPERATIONS 
 
 The report Risk of Injury and Compromised Performance Due to 
EVA Operations (Chappell et al., 2015) deals with issues surrounding 
EVA and is informed by a substantial amount of experience from EVA 
activities to date. The evidence report provides a strong overview of the 
relevant issues and describes the complexities of the hazardous environ-
ments faced in space exploration and the challenges in designing EVA 
suits and training regimens to overcome those hazards. This evidence 
report could be strengthened by additional discussion of alternative suit 
architectures and other topics outlined in the review that follows. 
 
Does the Evidence Report Provide Sufficient Evidence, as Well 
as Sufficient Risk Context, That the Risk Is of Concern  
for Long-Term Space Missions? 
 
 The report discusses the issues associated with suit design and pre-
sents data from the ISS and Apollo-era experiences; the report also in-
cludes results of studies conducted to identify characteristics of future 
suits to support EVA requirements during expedition-class missions. 
This evidence report provides a comprehensive review of both the exter-
nal hazards faced in EVA operations, particularly excessive radiation 
exposure and unviable breathing environments, as well as the hazards and 
challenges posed within the microclimate of the space suit such as hypox-
ia, humidity, suit pressure, and the biological challenges including thermal 
dysregulation, nutrition and hydration and waste removal needs. The re-
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port however lacks specificity concerning the types of EVA tasks that like-
ly will be performed during expeditions to asteroids, the Moon, or Mars.  
In addition, the report is predicated on the assumption that gas-
pressurized suit architecture (similar to that used during Apollo or on ISS 
EVAs) is the only option available, and all gaps addressed by the authors 
derive from this assumption. The rationale for leaving out a considera-
tion of alternative suit architectures, such as the Z-2 gas pressurized suit 
under development, or a mechanical counter-pressurized (MCP) suit, is 
not stated.  
 
Does the Evidence Report Make the Case for the  
Research Gaps Presented? 
 
 Seven research gaps are listed in the evidence report (numbered 6 
through 11 and 14; Box 2). The committee believes the evidence report 
authors adequately supported these seven gaps but did not provide justi-
fication for retiring previously identified gaps.  
 
BOX 2 
Research Gaps Identified in the Evidence Report 
 
• EVA 6: What crew physiological and performance capabilities are 
required for EVA operations in exploration environments? 
• EVA 7:  How do EVA suit system design parameters affect crew 
health and performance in exploration environments? 
• EVA 8: What are the physiological inputs and outputs associated 
with EVA operations in exploration environments? 
• EVA 9: What is the effect on crew performance and health of vari-
ations in EVA task design and operations concepts for exploration 
environments? 
• EVA 10: Can knowledge and use of real-time physiological and 
system parameters during EVA operations improve crew health 
and performance? 
• EVA 11: How do EVA operations in exploration environments in-
crease the risk of crew injury and how can the risk be mitigated? 
• EVA 14: What other EVA-related risks, developments and tech-
nologies exist that may affect EVA research? 
 
SOURCE: Chappell et al., 2015.  
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Gaps 1 through 5 and 12 and 13 are not mentioned in the evidence 
report. The IOM committee found that that gaps 1-5 had been retired by 
a 2009 Standing Review Panel (NASA, 2015). Gap 13 (EVA 13: What is 
the risk of hypoxia during exploration missions?) is listed on the NASA 
website as a current gap but is not included in the evidence report (Chap-
pell et al., 2015; NASA, 2015). Additionally, there may be a renumber-
ing issue as the website discusses the creation of EVA gaps 6-13 but then 
lists them as gaps 6-11 and 13-14 (NASA, 2015). The website notes:  
 
Following the 2009 Standing Review Panel, the EPSP 
[EVA Physiology, Systems, and Performance] Project 
conducted an extensive project portfolio review. Subse-
quently EVA gaps 1-5 were deleted, and EVA gaps 6-13 
were created to clarify the areas that should be addressed 
to mitigate this risk. Applicable tasks from EVA gaps 1-5 
(below) were mapped to the new EVA gaps. 
 
• EVA 1: What models and techniques are re-
quired to evaluate various suit designs and op-
erational concepts to optimize crew health and 
performance?  
• EVA 2: What are the physiological and bio-
mechanical stimuli associated with various 
suit designs and EVA tasks?  
• EVA 3: What suit characteristics, systems, and 
consumables requirements are needed to opti-
mize crew performance, health and safety?  
• EVA 4: What technologies and in-suit coun-
termeasures can be integrated into the EVA 
suit to optimize crew performance, health and 
safety?  
• EVA 5: How can decompression sickness 
(DCS) risk be characterized, mitigated, and/or 
treated? 
  
The committee recognizes that the retired Gap 5 on decompression 
sickness has now become a separate risk category with its own evidence 
report (see discussion below). Further, the Standing Review Panel’s revi-
sions focus the new gaps (see Box 2) on the physiological aspects of suit 
design as related to astronaut health and performance.  
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However, the committee believes that there is value in noting these 
changes in the evidence report and retaining the retired gaps by marking 
them as inactive (or some other similar notation) to ensure that all issues 
are carefully considered particularly in planning for EVA activities on a 
planetary surface. Because the evidence reports act as a repository for 
knowledge about risks and gaps in knowledge, the rationale for changes 
should be included in the evidence reports. This appears particularly im-
portant at a time when future planning for longer duration interplanetary 
missions will, of necessity, move from a situation of more certainty to 
one of less certainty. 
  
Are There Any Additional Gaps in Knowledge  
or Areas of Fundamental Research That Should Be Considered  
to Enhance the Basic Understanding of This Specific Risk? 
 
 Gap 6 in the evidence report asks “What crew physiological and per-
formance capabilities are required for EVA operations in exploration 
environments?” The report offers metrics to close the gap: aerobic fitness 
standard; muscle strength and power required; anthropometry; loss of 
physical function during transit to EVA site; and EVA activity contrib-
uting to physiological countermeasures. These are valid issues, but what 
is missing is a detailed understanding of the work that will be performed 
by the human crew outside the protection of a space ship or planetary 
habitat during expedition-class missions. All garments, from running 
shorts to elaborate protective ensembles are designed with an under-
standing of the tasks that will be performed while wearing them. The 
primary research gap missing from many of the NASA evidence reports, 
including this one, is the need for a systematic analysis of tasks likely to 
be performed by crew personnel during long-duration space missions. In 
conjunction with this, a method for evaluation of performance will be 
needed. Based on information presented in the evidence report, it is pos-
sible that the constraints imposed by conventional pressure-suit designs 
of the type described by the authors, while adequate for ISS EVA activi-
ties, might not support the surface operation requirements of planetary 
expeditions. Only a task analysis will determine the optimal design for 
suits to be used for EVAs on planetary surfaces. The task analysis will 
provide insights into the potential concerns and will define the require-
ments for suits. The optimal design will be defined by evaluating the 
available technologies and applying human factors design principles.  
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to assume that geological exploration and construction activities will be 
involved. In this regard, it is relevant to note that most of the physical 
injuries sustained by Antarctic analog personnel are trauma to the hands 
and feet (Stuster, 2010). Many of the injuries sustained in underwater 
training for EVA are at the shoulder with possible connection to suit de-
sign. For this reason, the possibility of abrasion and/or mechanical punc-
ture of suit materials during EVA should be addressed as a research gap 
as it could have potentially catastrophic consequences for astronaut safe-
ty. Similarly, the requirements for considerable muscle strength to oper-
ate gas-pressurized suits were established by the evidence report. 
Potential effects on accomplishing mission objectives, surviving emer-
gencies, and performing contingency operations should be considered.  
The evidence report discusses the Apollo EVA experiences in detail, 
and the committee believes that is appropriate as those 28 EVAs remain 
the only surface (non-Earth) EVAs to date. The following quotes from a 
review of the lessons learned during the Apollo missions (Scheuring et 
al., 2007) highlight some of the limitations of the conventional gas-
pressurized suit design. 
 
According to the Apollo lunar crews, the most fatiguing part of 
surface EVA tasks was repetitive gripping. Regarding the glove, 
one crewmember stated, “Efficiency was no more than 10% of 
the use of the hand.” The fingernails generally tended to be 
pulled back resulting in separation of the nail from the bed, or 
onycholysis. Additionally, the skin frequently was abraded from 
the top of the knuckles. This event took on operational and po-
tentially mission significance as several lunar walkers stated that 
they would not be able to work in the glove beyond the two to 
three EVAs they completed due to the swelling and pain over the 
bony prominences of the metacarpal phalangeal (MCP) and 
proximal interphalangeal (PIP) joints (knuckles), although had 
they been asked, it is probably that at least one more EVA would 
have been possible…. Designers should consider a wrist seal and 
depressurized glove. (p. 8) 
  
EVA suit mobility was more of an issue in terms of surface lo-
comotion and energy expenditure. The crews often felt they were 
fighting the resistance in the suit (including in the glove as men-
tioned above). This was fatiguing, especially in the thighs. The 
astronauts pointed out that the lunar surface is more similar to an 
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ocean than to a desert. The undulating surface posed a number of 
challenges, including ambulating against a suit that did not allow 
mobility at the hip. Normal human locomotion includes flexion 
at the hip and the Apollo A7LB had limited ability to bend the 
suit at the hip and to rotate within the suit. The crewmember had 
to bend forward from the knee joint, which demanded considera-
bly more work load on the quadriceps muscles. Therefore, the 
mobility recommendations centered on adding hip mobility and 
improved knee flexibility. One comment summed this point well, 
“Bending the knee was difficult in the suit. We need a better 
[more flexible] knee joint.” Reducing suit pressure to ~3.0 psia 
(sea-level oxygen partial pressure) with a pure oxygen system 
would accomplish this to some extent. (p. 9) 
  
EVA suit puncture hazard was a primary concern of the lunar as-
tronauts, although the risk was considered low. Astronauts sug-
gested that protecting suit occupants from a break in suit 
integrity was appropriate for future research and development 
activities. However, the trade-offs for this need to be considered 
carefully relative to mission rules if there is a puncture and 
emergency regulation of suit pressure and the availability of rov-
er consumables, etc. (p. 10) 
 
Does the Evidence Report Address Relevant Interactions  
Among Risks? 
 
 The evidence report identifies links to the evidence reports on inade-
quate human-computer interaction, training deficiencies, personnel selec-
tion issues, and mostly the risk of decompression sickness. Additional 
interactions that require attention include 
 
• Risk of Inadequate Nutrition (Smith et al., 2015): malnourished 
astronauts are at risk for physical failure during highly strenuous 
EVAs, 
• Risk of Reduced Physical Performance Capabilities Due to Re-
duced Aerobic Capacity (Downs et al., 2015): EVAs require 
aerobic stamina due to physicality of tasks, stiffness of gas suit, 
and 
• Risk of Impaired Performance Due to Reduced Muscle Mass, 
Strength, and Endurance (Ploutz-Snyder et al., 2015): EVA 
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requires strength to avoid fatigue and to accomplish EVA 
objectives. 
 
What Is the Overall Readability and Quality? 
 
 The evidence report is well written and understandable even for non-
experts, although editing would be helpful. The committee also noted 
that in several places the differences between underwater training and 
microgravity were not clearly stated or acknowledged. Underwater (neu-
tral buoyancy) training only partially simulates microgravity because one 
retains the 1-G gravitational forces on the balance organs and all internal 
organs. The committee also noted some need to distinguish between 
weight and inertial mass. Some terms, such as “non-optimized offload 
kinetics” (p. 8) should be defined. 
 
Is the Breadth of the Cited Literature Sufficient? 
 
Extensive literature is cited, but nothing concerning alternative suit 
designs is among the references. References that could be added include 
Holschuh, 2014; Newman et al., 2005; Waldie, 2005; Webb, 1968; Webb 
and Annis, 1967. 
 
Is the Expertise of the Authors Sufficient to Fully Cover the Scope 
of the Given Risk? 
Is Input from Additional Disciplines Needed? 
 
The authors and contributors to the report are all highly-qualified ex-
perts with expertise in suit design for deep-sea diving, aviation, and 
spaceflight and with experience in EVAs. Additional input is needed 
from experts who can evaluate alternative approaches to conventional 
pressure suits for expedition-class space missions. At the very least, the 
authors should explain why other approaches to suit design were not 
mentioned in the report. The issue should be addressed, even if the au-
thors believe that conventional design is the only possible solution to 
EVA requirements. The effects of radiation on human EVA capability 
also should be addressed in greater detail, along with actionable strate-
gies for mitigating radiation exposure during EVA.  
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Has the Evidence Report Addressed Previous Recommendations  
Made by the IOM in the 2008 Letter Report? 
 
The committee finds it noteworthy that the 2008 Letter Report made 
the following recommendations (among others):  
 
1. Reduce the risk of falling through use of better boots, gloves, 
biosuit (skin-tight suits), auxiliary displays, and navigation and 
terrain information. 
2. Study of alternate joint designs. (p. 51) 
 
The 2008 report also notes, under relevant interactions among risks, “the 
risk of poor task design.” The design of tasks that necessitate EVA must 
necessarily consider the physical and other limitations created by the 
suit.” The committee notes that the current evidence report reflects and 
addresses this recommendation, but would also add that the tasks antici-
pated during planetary surface exploration are in some ways fundamen-
tally different and need careful analysis.  
The evidence reports need to clearly distinguish EVAs during plane-
tary surface exploration from in-orbit EVAs. The evidence report authors 
could consider coining a separate term for EVAs conducted on a plane-
tary surface to distinguish the activity from EVAs conducted in Earth 
orbit (i.e., freefall or simulated microgravity). A term such as “planetary 
EVA” or “extra habitat activity” could be used to convey the fundamen-
tal differences in environmental conditions and human and equipment 
requirements.  
The committee also highlights the need to ensure that crewmembers 
be able to be individually distinguished in their spacesuits; color-coding or 
distinguishing marking will be necessary for asteroid and planetary explo-
ration. During development of the Z-2 suit, another pressurized suit, 
NASA circulated a large number of photos and drawings, many of which 
show luminescent patches. These could be color-coded (see Figure 4). 
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Does the Evidence Report Provide Sufficient Evidence,  
as Well as Sufficient Risk Context, That the Risk Is of Concern  
for Long-Term Space Missions? 
 
Based on our current understanding of the factors contributing to 
DCS—derived predominantly from experience gained in diving and dur-
ing high-altitude operations on Earth—the authors provide a clear case 
for the risk of DCS during future human space exploration EVAs. Ac-
cording to current understanding, as long as astronauts are tasked with 
conducting EVAs in suits with lower operating pressures than the pres-
sures in their vehicle or habitat, the risk for DCS exists. However, this 
risk assessment includes two fundamental assumptions: 
 
1. The causal mechanisms for DCS in space are the same as those 
on Earth (i.e., the understanding of the physiologic response to 
decompression in micro- or partial-G environments is accurate) 
2. EVAs will be conducted in suits at lower operating pressure than 
the vehicle or habitat  
 
Based on the evidence provided in the report, it is unclear whether 
these assumptions are valid. Testing of current astronaut pre-breathe pro-
tocols on Earth leads to an expected in-space DCS incidence rate of ap-
proximately 20 percent; however, no in-space DCS incidents have been 
reported in the history of the space program. The source of this discrep-
ancy is not currently understood, although theories are posited in the evi-
dence report (including a lack of symptoms, confusion regarding 
symptoms, or a lack of willingness to report symptoms).  
The assumption that EVAs will be conducted in a low-pressure, gas-
pressurized suit, ignores the prospect of alternate suit architectures. For 
example, MCP suits, such as the Space Activity Suit or the Massachu-
setts Institute of Technology (MIT) BioSuit, pressurize the wearer using 
tight fitting materials rather than pressurized gas, enabling suits to oper-
ate at higher pressures without necessarily limiting astronaut mobility. 
As previously noted, NASA is investigating these technologies (e.g., a 
2015 call for MCP glove development has been recently awarded), 
which could have significant implications for future DCS risk in space. 
This report does not appear to consider such alternatives. 
The uncertainty behind these assumptions needs to be resolved in or-
der to know with confidence the magnitude of DCS risk (if any) that 
needs to be addressed in future human space missions. 
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Does the Evidence Report Make the Case for the  
Research Gaps Presented? 
 
The evidence report identifies seven research gaps in DCS 
knowledge: 
 
DCS 1. We have not defined the acceptable DCS risk with respect 
to the work efficiency index for exploration scenarios.  
DCS 2. We do not know the contribution of specific DCS risk fac-
tors to the development of DCS in the spaceflight explora-
tion environment.  
DCS 3. We do not know the mission related factors that contribute 
to DCS risk.  
DCS 4. We do not know to what extent physiological and envi-
ronmental factors can be incorporated and validated in a 
model of DCS for micro and reduced gravity.  
DCS 5. We do not know what validated procedures will adequate-
ly prevent DCS.  
DCS 6. We do not know what new developments related to DCS 
will come from other investigators.  
DCS 7. We have not validated procedures to adequately treat DCS 
in the spaceflight environment should it occur.  
 
These gaps are well supported by the report: fundamental DCS dy-
namics are poorly understood (e.g., gas bubble formation, growth, and 
movement), and the existing DCS model and protocols have not been 
validated for future exploration design reference missions. The commit-
tee believes that the gaps listed by NASA outline many (but not all) of 
the gaps in understanding of the risks associated with DCS in human 
space exploration. Gap 5 could be restated to be more specific to long-
duration/planetary exploration missions, as the current pre-breathe proto-
cols have been used by spacewalkers with no adverse events and a focus 
is needed on exploring protocols for different environmental conditions, 
particularly planetary environments. Gap 6 as stated in the evidence re-
port (and listed above) does not point to a specific gap but states an obvi-
ous process in science—the potential for new developments. NASA 
could consider deleting or revising this gap statement.     
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Are There Any Additional Gaps in Knowledge  
or Areas of Fundamental Research That Should Be Considered  
to Enhance the Basic Understanding of This Specific Risk? 
 
The following specific gaps in knowledge are highlighted (in no par-
ticular order), some of which may be partially encompassed by the pre-
viously enumerated list, and others, which represent new and unique 
gaps. These gaps warrant additional research to best understand the risk 
of DCS in human space exploration: 
 
• Task analysis: Specific, mission-focused task analyses are need-
ed for future EVAs in micro- and partial gravity. Future EVAs 
may more closely resemble Apollo-style surface exploration 
(characterized by locomotion and full-body activity) than the 
current paradigm of zero-G, ISS-style EVAs (which consist pre-
dominantly of arm/hand manipulations with an anchored lower 
body). Consequently, it is critical that the set of expected tasks to 
be performed in future EVAs are established and characterized 
and that there is an understanding of the energetics of those ac-
tivities. Knowing that the EVA represents the “altitude” phase of 
the decompression cycle (when DCS risk is at its highest), ex-
pected exertion for EVA tasks needs to be well understood, as it 
may affect the type and duration of EVA operations that are fea-
sible (or add additional requirements for suit mobility). 
• Risk profiles: Information is needed on the composite risk pro-
file for (and variance within) individuals likely to be selected as 
astronauts on long-duration missions (e.g., middle-aged men and 
women), so recommendations for crew selection can be based on 
minimizing risk. It is known that the astronaut population is self-
selected to be generally healthy and that the risk of DCS varies 
in individuals both within and between demographics; however, 
much remains to be learned about individual variation (e.g., why 
certain divers are less susceptible to DCS and why some acclima-
tize, whereas others sensitize in the face of repeat exposure) or 
what defines an “ideal” demographic for long-duration spaceflight 
with respect to DCS risk (there may be conflicting “ideal” de-
mographics, depending on which physiological risk is prioritized).  
• DCS dynamics: More needs to be understood about the differ-
ences, if any, in DCS dynamics in a zero- or partial-G environ-
ment compared to a 1-G environment (and the lack of definitive 
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explanation for the current discrepancy between expected and 
actual DCS incidents in space). Knowledge of, and protocols for, 
DCS are necessarily developed and tested in 1-G environments, 
and to date they have only been operationally validated in mi-
crogravity (on the ISS). Experience with planetary EVA is lim-
ited, and experience with planetary EVA following a long-
duration microgravity transit is non-existent. Exploring DCS dy-
namics in varying gravity environments includes examining 
what, if any, changes these differences have on the risk of DCS 
onset in these regimes, and what, if any, changes these differ-
ences have on Earth-based protocol validation strategies.  
• Alternate suit architectures: Cost–benefit analyses are needed of 
alternate suit architectures with respect to reducing DCS risk. As 
discussed earlier regarding the EVA evidence report, advanced 
mobility suit concepts such as MCP suits offer significant ad-
vantages over gas-pressurized suits (and can potentially be oper-
ated at higher pressures with less effort, decreasing both the 
difference between vehicle and suit pressure and the energetic 
cost of EVAs, thereby doubly decreasing DCS risk). While these 
suits are not operationally viable today, more research needs to 
be conducted to determine the cost-benefit of advancing MCP 
technology to flight-level capability.  
• Pre-breathe protocols: Specific risks associated with interrup-
tions of otherwise-validated pre-breathe protocols need to be un-
derstood. It is clear that these types of interruptions are 
unavoidable in practice, although little explanation or justifica-
tion is provided for the established protocol in these cases (two 
times payback time relative to interruption length, or four times 
payback time if the break occurs “early in the exercise proto-
col”). This area is ripe for additional study enumerating or min-
imizing likely sources of interruption (i.e., operations); the 
physiological effects of pre-breathe interruption and the variance 
in individual response (i.e., physiology); and advanced mitiga-
tion strategies with targeted treatments for individuals with dif-
fering susceptibility (i.e., advanced technological and medical 
intervention strategies). 
• Technologies: Further understanding how to monitor and diag-
nose DCS will necessitate reliable, portable, and safe technolo-
gies to monitor and diagnose DCS. Previous attempts at in-suit 
monitoring (venous gas embolism monitoring via in-suit Doppler 
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detector) were discontinued despite showing promise. The com-
mittee recognizes that there are conflicting priorities between in-
corporation of in-suit technology and reduction of risk of fire 
within the suit, however the decision to discontinue in-suit moni-
toring for DCS needs to be revisited because of the potential 
benefit that such monitoring may offer the astronaut on long-
duration missions. Further, the establishment of a reliable bi-
omarker for DCS diagnosis purposes would help immensely in 
understanding the prevalence of DCS (independent of subjective 
reporting) and in validation of future pre-breathe protocols.  
• Operationally efficient pre-breathe protocols for long-duration 
missions: Given the complete absence of DCS in space to date, it 
is theoretically possible that existing protocols could be short-
ened without compromising safety. The committee encourages 
NASA to explore this possibility, as a streamlined pre-breathe 
protocol would enable crew time to be spent on more productive 
activities.  
• DCS treatment: More robust treatment mechanisms should be 
developed. A detailed strategy for treating moderate-to-severe 
DCS on a long-duration mission is needed as is the infrastructure 
necessary to provide treatment should DCS occur. As it stands, 
the last-ditch response is to over-pressurize the operational EVA 
suit to provide repressurization, compromising the suit in the 
process. This is not an acceptable intervention on a deep-space 
mission, where resupply is impossible, as it puts future EVAs 
(and therefore mission success) at extreme risk. 
• Intra-personal variances throughout long-duration missions: 
Physiological deconditioning over the course of a long mission 
may affect an individual’s relative DCS susceptibility. Long-
duration spaceflight potentially can cause deconditioning and al-
teration of many physiologic systems (e.g., bone density and 
muscle mass loss, weakening of cardiac output, fluid shifts, vi-
sion changes). Currently it is not known how an individual’s 
specific DCS risk changes as they decondition or how much var-
iance there is in individual risk for a given change in these phys-
iologic systems. These interrelated effects, which may manifest 
part way through a long-duration mission, warrant additional 
study to understand their effect on total DCS risk.  
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Does the Evidence Report Address Relevant Interactions  
Among Risks? 
 
The report is thorough, and through the discussion provided by the 
authors, interactions are frequently addressed. Table 6 (Individual Fac-
tors Associated with Risk of DCS and Venous Gas Emboli, p. 39) of the 
report enumerates several known risk factors for DCS (age, patent fora-
men ovale [a relatively common and generally benign defect of the heart 
involving a passage in the heart wall], sex, menstrual cycle time, aerobic 
fitness, body fat, hydration systems). The committee concurs with these 
risk factors, and volunteers additional relevant interactions based on oth-
er evidence reports compiled by NASA, including 
 
• Risk of Injury and Compromised Performance Due to EVA Op-
erations (Chappell et al., 2015) 
• Risk of Inadequate Task Design (Sándor et al., 2013) 
• Risk of Reduced Physical Performance Capabilities Due to Re-
duced Aerobic Capacity (Downs et al., 2015) 
• Risk of Impaired Performance Due to Reduced Muscle Mass, 
Strength, and Endurance (Ploutz-Snyder et al., 2015) 
• Risk of Performance Decrement and Crew Illness Due to Inade-
quate Food System (Perchonok et al., 2012) 
• Risk of Inadequate Nutrition (Smith et al., 2015) 
• Risk of Unacceptable Health and Mission Outcomes Due to Lim-
itations of In-Flight Medical Capabilities (Archibald and Kelleher, 
2015) 
 
In the committee’s opinion, these are relevant risk interactions be-
cause they include those with a direct effect on DCS risk (e.g., suit sys-
tems and EVA task allocation), those which systemically decondition the 
astronaut which may increase his or her susceptibility to DCS (e.g., envi-
ronmentally-induced issues such as cardiac and muscle loss, as well as 
nutrition-induced issues), and those with a direct effect on DCS treat-
ment (e.g., lack of in-flight treatment capabilities). 
 
What Is the Overall Readability and Quality? 
 
The report is of high quality—it is scholarly, complete, well written, 
and the conclusions follow from the data presented. Two small points of 
confusion in equations presented in the evidence report were identified. 
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First, Equation 1 (p. 7) needs to be clarified (Conkin et al., 2013). The 
committee has previously seen the supersaturation equation formulated 
differently (Davis et al., 2008):  
 
Supersaturation   −+= avg PPP  
 
where Pg is the sum of the tensions of all dissolved gases; Pv is the sum of 
vapor pressures; and Pa is local absolute pressure. This appears to be a 
slightly different statement than Equation 1 in the evidence report. Are 
they equivalent, or should Equation 1 in the report be updated? 
Second, the bubble growth equation (defined on page 22 of the evi-
dence report) contains the following term. This term has also been writ-
ten without the negative sign in previous evidence reports (Gernhardt et 
al., 2009, p. 351). 
 
),( trh
Dα−
 
  
This confusion highlights the necessity to carefully reference key 
material such as equations used to model complex systems.  
 
Is the Breadth of the Cited Literature Sufficient? 
 
The report carries an impressive bibliography, with more than 230 
sources cited. However, the committee concurs with the 2014 DCS Risk 
Standing Review Panel (Steinberg et al., 2014) that additional literature 
review areas could strengthen the report: 
 
• Work by Thom and colleagues at University of Maryland on mi-
cronuclei particles  
• Work by Flagg and colleagues on pre-breathe interruption  
• Work by the U.S. Navy at the Navy Experimental Diving Unit 
and Naval Submarine Research Lab relating to EVA operations 
and limited resource allocation  
• Reports on the U.S. Air Force Manned Orbital Laboratory Pro-
gram focusing on manned long-term low-pressure exposures 
• Specific research related to U2-pilot DCS (e.g., Jersey et al., 
2013; McGuire et al., 2013; Pilmanis et al., 2010)  
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• A review of research focusing on human adaptation to hypoxic 
and high-altitude environments 
• Work on pre-breathe interruption (Conkin, 2011; Pilmanis et al., 
2010) 
• Work by Buckey and colleagues on DCS instrumentation (Buckey 
et al., 2005) 
 
Please refer to the 2014 DCS Standing Review Panel for detailed ci-
tation suggestions (Mahon et al., 2014).  
 
Is the Expertise of the Authors Sufficient to Fully Cover 
the Scope of the Given Risk? 
Is Input from Additional Disciplines Needed? 
 
The committee believes that the expertise of the authoring team is 
more than sufficient to cover this topic area. The team has a deep and 
diversified range of backgrounds and expertise (including physicians, 
DCS researchers, and EVA and suit experts). The authoring team for the 
evidence report has done a good job interfacing with additional disci-
plines to assess DCS risk. As described earlier, due to the significant ef-
fect of both space suit architecture and EVA task selection on DCS risk, 
the committee encourages the DCS community and EVA suit and opera-
tions communities to continue working closely to mitigate this risk. Fur-
ther, because of the difficulty and uncertainty in assessing and treating 
DCS in-situ, the authors are encouraged to more closely interact with the 
medical and space technology communities on sensing (e.g., in-suit 
wearable technologies such as venous gas emboli Doppler sensors, or 
reliable biomarkers) and treatment protocols and technologies (e.g., re-
pressurization suits or Gamow bags).  
 
Has the Evidence Report Addressed Previous Recommendations 
Made by the IOM in the 2008 Letter Report? 
 
DCS was not included as an independent risk in the 2008 IOM re-
port, but it was included in Chapter 8 “Compromised EVA Performance 
and Crew Health Due to Inadequate EVA Suit Systems.” The committee 
feels that in pulling DCS out as a separate risk, NASA has responded to 
the spirit of the 2008 report.  
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RISK OF PERFORMANCE DECREMENT AND CREW 
ILLNESS DUE TO AN INADEQUATE FOOD SYSTEM 
 
The risks in the NASA evidence report Risk of Performance Decre-
ment and Crew Illness Due to an Inadequate Food System (Perchonok et 
al., 2012) are broken down into three components: inadequate food safe-
ty, inadequate nutritional content of food and intake, and inadequate ac-
ceptability of food. Evidence of constraining food system resources was 
also presented. 
 
Does the Evidence Report Provide Sufficient Evidence,  
as Well as Sufficient Risk Context, That the Risk Is of Concern  
for Long-Term Space Missions? 
 
As mission length increases and return to Earth becomes impossible 
at specific points, the closed system nature of the food supply becomes 
an increasingly pressing concern. While the feasibility of growing plants 
in space has been demonstrated on the ISS, it appears likely that any 
long-duration mission beyond low Earth orbit must pack sufficient food 
for the journey. The evidence report demonstrates sufficient evidence 
that this risk is of concern.  
 
Food Safety 
 
Food safety is of concern on Earth and in space. However, the risk 
associated with food safety issues can potentially be more catastrophic in 
space. Without information on intervention or cure protocols and the 
training that astronauts receive, the true severity of the risk cannot be 
assessed. Additionally, the risk could be higher in space if package integ-
rity may be compromised to a greater extent during spaceflight than on 
Earth due to physical, thermal, or radiation exposures. The risk could 
also be higher if thermophilic spoilage microorganisms could grow dur-
ing transportation or storage which would not normally occur on Earth. 
The risk associated with the presence of food waste and use of alternative 
technologies (for producing some foods on the mission) such as hydro-
ponics can increase safety concerns, and these are addressed in the evi-
dence report. 
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Nutritional Content of Food and Intake 
 
Weight loss for astronauts has been documented in a number of pre-
vious space missions (Perchonok et al., 2012). Inadequacy of nutrients 
provided in Apollo missions in comparison to required levels of nutrients 
has been documented as discussed in the evidence report, as have de-
creased levels of vitamins and minerals in blood, urine, and serum. Sig-
nificant changes in nutrient levels during extended storage has also been 
documented, and studies of nutrient losses during controlled storage are 
ongoing. 
 
Acceptability  
 
The level of consumption of food is related to the acceptability of the 
food. Debriefing of crewmembers has indicated the need for variety in 
types of food to enhance mood and consumption of the food. Additional-
ly, foods were pre-positioned at the ISS and a decrease in the number of 
crewmembers sent to the ISS resulted in 3-year-old foods remaining on 
site and needing to be consumed, thereby causing a decrease in accepta-
bility and consumption of the food. Long-term use effects for defined 
diets still need to be assessed. 
 
Constraining Food System Resources 
 
People are used to consuming certain foods when they are hot and 
certain foods when they are cold. However, systems for heating and 
cooling foods may not be readily available during spaceflight due to 
weight and volume constraints. The need for heating and cooling of 
foods to make them acceptable has been documented based on interviews 
with crew. 
One common factor that has not been adequately addressed in this 
evidence report is the relationship between any of the factors discussed 
and the level of performance of required tasks. A concerted coordinated 
effort is needed. 
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Does the Evidence Report Make the Case for the  
Research Gaps Presented? 
 
The evidence report details the following research gaps and provides 
the evidence and the concerns regarding each of these gaps: 
 
• AFT1: How can the food system deliver the required level of nu-
trition throughout the mission?  
• AFT2: How can the nutrition and acceptability of the food sys-
tem be maintained throughout the mission?  
• AFT3: How can the acceptability of the food system be main-
tained throughout the mission?  
• AFT4: What technologies can be developed that will efficiently 
balance appropriate vehicle resources such as mass, volume, 
and crewtime during exploration missions with the safety, nutri-
tion, and acceptability requirements? (Perchonok et al., p. 5)  
 
The report discusses the issues regarding kinetic models available to 
date that are not accurate enough to predict the true shelf life of a given 
product, especially under extended storage time at the intended condi-
tions for long-duration missions. Additionally, the models indicate that 
several of the existing foods deemed acceptable for current space mis-
sions will not be acceptable for longer duration missions. This justifies 
the need for exploring alternative technologies for preparing, processing, 
packaging, and storing foods and also developing more accurate models 
for predicting the shelf life of products. Such models can make use of the 
2 to 3 additional years of the storage study data collected by NASA 
(Cooper et al., 2011) as well as the ongoing storage study of similar mili-
tary ration items that are underway at the U.S. Army Laboratories in Na-
tick, Massachusetts. Ongoing communications and collaborations with 
the Natick research team are encouraged. 
The need to develop methods to minimize the residual level of oxy-
gen within a package has been properly identified in the evidence report. 
The need for developing high-barrier packaging materials that are light-
weight and easily disposed has also been appropriately addressed. 
Food waste and packaging waste have been documented in the evi-
dence report to be a leading category of waste during space exploration 
missions. Thus, the need to develop strategies to minimize these is evi-
dent. The need to develop bioregenerative systems has been mentioned. 
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This section could be strengthened with appropriate references on the 
technologies that are currently available. 
The possibility of using probiotics to potentially enhance the health 
and well-being of crewmembers was mentioned. However, data on sur-
vival of these probiotics during extended periods of time are needed as 
are data on the link between probiotics and preventing illness (and im-
proving performance). 
 
Are There Any Additional Gaps in Knowledge  
or Areas of Fundamental Research That Should Be Considered  
to Enhance the Basic Understanding of This Specific Risk? 
 
Understanding Food Safety and Processing Technologies 
 
Although inadequate food safety was listed as a concern, it has not 
been listed as one of the areas of fundamental research that should be 
conducted in the list of gaps at the bottom of page 5 of the evidence 
report. Perhaps there was a typo or some duplication between Gaps 2 and 3 
(p. 5). Safety assurance measures currently in place for prepackaged foods 
on spaceflights were well covered.  However, growing or processing foods 
from bulk ingredients during the mission do present challenges. For ex-
ample, some dry ingredients previously thought to be safe have been 
found to harbor surviving Salmonella species that can cause illness (Finn 
et al., 2013). Added safety assurance measures or improved processes 
should be investigated for some basic ingredients such as milk, egg pow-
ders, or flour.  
The shelf life and quality of a product depend on the ingredients 
used, processing technologies adopted, packaging employed, and storage 
conditions (EUFIC, 2013). Developing and using high-quality ingredi-
ents could potentially result in the production of nutrient dense foods 
with acceptable nutritional value and shelf life. However, it is also im-
portant to understand how bioavailability and bioaccessibility of these 
nutrients are affected by storage in space or a planetary surface. A re-
examination of freeze-dried foods, especially for items to be used in con-
gregate meals, should be conducted with a look at ingredients that may 
minimize cross-linking that inhibits rehydration during extended storage. 
Such items can achieve a 5-year shelf life when packaged in high-barrier 
packaging (Perchonok et al., 2003). The use of emerging rapid heating 
processes (with ohmic, microwave or radio frequency technologies), 
short holding, and rapid cooling or other alternative sterilization technol-
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ogies, including irradiation (Josephson, 2015), which has been used on 
previous space missions, could result in improved product quality with 
longer shelf life. The development of lightweight high-barrier edible 
films can address shelf life and waste issues simultaneously (Cooper et 
al., 2011). Additionally, it is important to understand the mechanisms 
behind the loss in integrity of a package due to physical, thermal, and 
radiation effects during transportation and storage. Understanding the 
effect of storing a product at extremely low temperatures that could be 
found in parts of the space vehicle is important in determining if this op-
tion could yield the desired quality and shelf life for a product for long-
duration missions. 
Fundamental studies addressing the understanding of the kinetics of 
detrimental reactions, including oxidation and cross-linking of food mac-
romolecules during long-term storage and developing the appropriate 
accelerated shelf life studies should be conducted. The use of time–
temperature integrators to monitor product quality and acceptability dur-
ing missions could help bridge the gap between existing kinetic models 
and reality. Effect of factors other than temperature (such as radiation 
exposure during flight or on planetary surfaces) on shelf life should also 
be considered. 
One of the issues that was mentioned in the report is the potential for 
partial gravity to affect heat and mass transfer for preparation or pro-
cessing of foods. Conducting mathematical modeling studies would be 
one way to address this issue to assess if the changes pose safety or 
quality issues. 
Another gap in information relates to appetite and satiety. A thor-
ough investigation on what causes loss of appetite in space is warranted, 
which should include the effects of taste and flavor perception in space. 
The types of foods that are preferred during spaceflights may be quite 
different from those on Earth. The use of nanotechnology to increase the 
surface area or encapsulation of desirable sensory markers (such as spic-
es or flavors) could enhance the acceptability of foods (Sekhon, 2010). 
The use of three dimensional printing can enhance the variety and 
freshness of foods that might be produced during long-term missions. It 
is important to understand how this approach could affect food safety, 
morale, time of preparation of food, and overall acceptability. 
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Impact on Human Performance 
 
One of the hypotheses in the report relates to performance decrement 
of crew as a result of lower levels of nutrition and calories. To substanti-
ate this hypothesis, it would be appropriate to develop the benchmarks 
for the nutritional and caloric needs to perform various tasks and also 
quantify how performance decreases as nutritional and caloric intakes 
decrease below the threshold values. Here, the Food Systems group 
could profitably work with the NASA Nutrition group and consult the 
published research on nutrition and human performance conducted by 
U.S. Army researchers. One such reference (Friedl and Hoyt, 1997) is 
cited in the evidence report.  
 
Utilization of Waste 
 
Research on the use of waste generated in space, especially on plane-
tary surfaces, should be conducted. This includes both food waste and 
packaging waste. Solid waste could potentially be used to generate ener-
gy, liquid waste could be reclaimed as potable water, and packaging 
waste could potentially be used to shield against radiation or other uses. 
Consideration should be given to exploring improved packaging of foods 
for long-duration missions that would have inner non-stick coatings to 
minimize adherence of food to the package, thereby maximizing food 
consumption and minimizing waste and the safety concerns associated 
with residual food. 
Research on developing lighter heating and cooling devices should 
be investigated so as to increase the acceptability of foods by maintain-
ing foods hot or cold, as desired. This could involve research on Peltier-
effect systems or thermoelectric generators. 
 
Does the Evidence Report Address Relevant Interactions  
Among Risks? 
 
Interaction effects between microgravity, radiation, temperature, and 
time on the safety, quality, and acceptability of foods has been hypothe-
sized. However, the quantification of the effects has not been done. Ad-
ditionally, the interaction between payload constraints on the ability to 
prepare, store, or serve foods and the acceptability of foods (both from a 
nutritional and sensory standpoint) has not been appropriately addressed. 
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The availability of sufficient potable water for drinking and food prepa-
ration at each stage of the missions should not be overlooked.  
 
What Is the Overall Readability and Quality? 
 
Overall the report is well written and the information is clearly and 
logically presented. However, information on newer processing and 
preparation technologies is somewhat lacking in the report because of the 
time lag from the report’s preparation in 2012 to current date. This is an 
area of rapidly evolving technologies and all efforts to update the evi-
dence report as often as possible would be useful.  
 
Is the Breadth of the Cited Literature Sufficient? 
 
Based on the date of the report, the breadth of the cited literature is 
appropriate. However, since the report was prepared more than 2 years 
ago, there have been several key developments, especially in the area of 
food-processing technologies. The most recent citations from 2012 were 
all internal NASA reports. Additional details on these focal areas have 
been given in the question above that addresses additional gaps. 
 
Is the Expertise of the Authors Sufficient to Fully Cover 
the Scope of the Given Risk? 
Is Input from Additional Disciplines Needed? 
 
Together the authors have a combination of technical, experiential, and 
historical knowledge to adequately address the issue under consideration. 
Input from engineering and chemistry (from the standpoint of under-
standing kinetics of deteriorative reactions, the rate of heat transfer, and 
extent of mass transfer during transportation and storage) and behavioral 
sciences (from the standpoint of understanding the relationship between 
types of foods, change in preferences during spaceflight and micro-
gravity, and the effect of a different social environment on satiety and 
well-being) could be beneficial in formulating the appropriate types of 
foods. Understanding the link between level and timing of exercise and 
sleep on quantity of food intake (and hence, nutritional intake) could be 
beneficial. Further, communications between the Food Systems and Nu-
trition Research evidence report teams could improve the joint focus on 
food and nutrient intake on human performance and behavior.  
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Has the Evidence Report Addressed Previous Recommendations  
Made by the IOM in the 2008 Letter Report? 
 
This risk did not appear as a separate chapter to be addressed by the 
2008 letter report. The closest identifiable risk, “Chapter 12 Inadequate 
Nutrition,” maps to the corresponding report (see below). The committee 
feels that creating a separate risk and associated evidence report is an 
appropriate response to the spirit of the 2008 report. 
 
 
RISK FACTOR OF INADEQUATE NUTRITION 
 
The need for adequate nutrition, particularly for long-term space 
missions, is self-evident and complex. What is challenging in addressing 
this topic is how to cover the breadth and depth of the many areas of nu-
trition while focusing in on the most relevant issues regarding the risks 
for long duration space missions.  
 
Does the Evidence Report Provide Sufficient Evidence,  
as Well as Sufficient Risk Context, That the Risk Is of Concern  
for Long-Term Space Missions? 
 
The focus of answering this question shifts to whether the evidence 
report provides sufficient risk context and specific relevance to space-
flight, particularly for long-term missions where most foods will be 
packaged shelf-stable items. Due to the breadth of the topics this report 
has to address, it is important to strengthen the report’s focus on the im-
pact of nutrition on human performance during long-term missions and 
to clarify throughout the report whether the experimentally derived nutri-
ent data discussed is referencing in vitro, animal, or human data. 
 
Does the Evidence Report Make the Case for the  
Research Gaps Presented? 
 
Data are provided to make the case for research gaps presented in the 
evidence report, however in some cases the evidence is over-stated (for 
example, the statement “Abundant data show that eicosapentaenoic acid 
can successfully prevent muscle atrophy in other muscle-wasting circum-
stances, such as cancer or sepsis (134-140, 143)” [p. 31]). This assertion 
is supported by eight citations, all include the same author and one is a 
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study in children. The relevance of these references to different stresses 
encountered in long-term space missions needs to be examined. The sec-
tion on essential fatty acids, especially the omega-3 fatty acids with their 
wide physiological impact, needs to be updated (see, for example, Jonas 
and Montain, 2014).  
The evidence report is uneven in its descriptions of nutrients and 
their risks of deficiencies or excesses. For example, folate deficiency is 
said to be “catastrophic” but not deficiencies of other equally essential 
nutrients. Risks for nutrient deficiencies seem over stated with worst case 
of death predominating. The real risk would seem to be in performance 
decrements from inadequate intake of nutrients.  
Dated and incorrect assertions need to be updated. For example, the 
report asserts “toxic levels of fat lead to high serum cholesterol, obesity, 
atherosclerotic plaques, and, ultimately, coronary heart disease, or even 
death” (p. 32). However, fat has not been found to be toxic, and nutri-
tionists generally do not recommend low-fat diets anymore (McManus et 
al., 2001; USDA/HHS, 2015). Moreover, total fat intake is only weakly 
associated with obesity. Overall deficient caloric intake or water intakes 
seem to be dominant risks. One suggestion would be to focus on those 
nutrients with intakes on space missions of some duration shown in the 
tables in the evidence report’s appendix that are either above (sodium, 
phosphorous) or below (vitamin D, vitamin E, total calories) standards 
for space flight.  
As presented, the evidence report does not appear to have any con-
sistent criteria for citations, as primary studies are mixed in with reviews 
and commentaries, and narrative reviews with systematic reviews. Much 
of the data cited in the report have been derived from short-term space-
flights or bed rest, without an explicit attempt to address the issues that 
would be associated with long-term flights, and some assertions related 
to short-term effects have since been debunked by longer-term studies. 
Statistical significance is frequently noted in the report, but assessment 
of whether such statistically significant differences have biological im-
portance is largely absent. Some of the shortcomings of bed rest studies 
are mentioned, but weighting of their evidence is not critically addressed. 
The report frames the importance of the inadequate nutrition in a mi-
crogravity environment but does not mention other stressful aspects of 
spaceflight that will affect human metabolism and the need for optimal 
nutritional support (e.g., radiation, isolation, or confinement) that have 
relevance to nutritional requirements. These can be important because 
they may affect reactive oxygen species, also mentioned in the report. In 
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addition, interaction of the stresses may create effects that are different 
than any of the stresses alone, and this is not discussed. 
Research gaps are presented without any attempt to prioritize their 
importance. The report would be strengthened by stripping out data that 
are not corroborated by long-term studies. Indeed almost all the 24 mi-
cronutrients discussed have the identical gaps identified, that their con-
tent and stability in space foods are unknown. The evidence report on 
Food Systems discussed above (Perchonok et al., 2012) notes that pro-
gress is being made in conducting nutritional analyses. The Nutrition 
evidence report would greatly benefit by including more evidence on nu-
trient stability in food and supplements from the NASA food systems team 
and relevant data on storage stability of nutrients in combat rations from 
studies being done at the U.S. Army laboratories in Natick, Massachusetts.  
The negativity evident in the report with respect to supplements oth-
er than vitamin D may not be appropriate, particularly for long-duration 
missions where fresh fruits and vegetables will not be available. This 
should be re-examined, especially in regard to water-soluble labile nutri-
ents for which excess doses are not physiologically harmful. 
The field of nutrition is moving rapidly, and the report as written is a 
traditional and somewhat dated catalog of properties of nutrients. It 
would benefit by updating to include the current state of knowledge 
about the following: 
 
• Nutrient stability in food, together with evidence of absorption, 
bioavailability, and bioactivity  
• Nutrients (e.g., omega-3 fatty acids and certain amino acids or their 
metabolites) operating as signaling molecules to influence metabol-
ic pathways and the transcriptional regulation of the genome 
• C-1 metabolism and its role in metabolism and gene regulation 
• Cofactors of methylation, vitamin B12 and folate, and the ig-
nored methyl donors especially choline (declared an essential nu-
trient by the IOM in 1998) and the amino acid methionine, and 
other sulfur compounds (IOM, 2006; Zeisel and Caudill, 2010; 
Zeisel and Corbin, 2012; Zeisel and da Costa, 2009; Zeisel et al, 
2003)  
• Effects of omega-3 fatty acids as well as the dietary omega-3 to 
omega-6 ratio on diverse stress and inflammatory responses and 
interaction with high protein diets on renal stone formation (Jonas 
and Montain, 2014) 
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• Inclusion of the lessons learned in clinical experience with total 
parenteral nutrition and in military nutrition research starting 
with the pioneering nutrition research of C. Frank Consolazio 
and colleagues in the 1940s carried into the present day. Many 
major thrusts are captured in published reports of the IOM 
Committee on Military Nutrition Research (IOM, 1999) 
• Effects resulting from studies of timing of food intake relative to 
exercise, and nutritional effects of circadian shifts and sleep habits 
 
Are There Any Additional Gaps in Knowledge or Areas 
of Fundamental Research That Should Be Considered  
to Enhance the Basic Understanding of This Specific Risk? 
 
Behavioral health is not adequately covered in the report, and addi-
tional understanding is needed of the inflight biochemical and psychoso-
cial factors that contribute to appetite, palatability and taste perception, 
satiety, and astronauts not consuming available foodstuffs completely. 
These factors will be especially important in deciding feeding strategies 
for long missions that may include planetary exploration missions. A 
relevant study not referenced was conducted by the IOM Committee on 
Military Nutrition Research, Not Eating Enough, Overcoming Undercon-
sumption of Military Operational Rations (IOM, 1995).  
Additional gaps that should be considered include the following: 
 
• Nutritional effects of altered microbiota, particularly for nutri-
ents such as vitamin K that are acquired primarily from microbi-
al metabolism rather than from diet.  
•  The overall health effects of interactions among nutrients, diet 
patterns, astronaut nutrition preflight baselines, and personal 
choices regarding diet. For example, Mediterranean and Western 
diets of similar nutrient composition have divergent long-term 
effects on cardiovascular health. 
• Individual variation in binding affinities for some needed en-
zymes (e.g., thiamine and thiamine phosphate coenzyme) as well 
as the metabolism and absorption of certain micronutrients (e.g., 
vitamin B12 and choline). 
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Does the Evidence Report Address Relevant Interactions  
Among Risks? 
 
Risk interactions are described, but they would be strengthened by 
addressing the following additional interactions. Food consumed by as-
tronauts in inflight environments may result in altered microbiota, which 
in turn can have physiologically important effects. These include the 
possibility of inflammation of specific sites (such as the intestines), 
which would potentially affect muscle loss, bone loss, and other physio-
logical systems. The microbiome also has known effects on the immune 
system, and emerging data suggests that there may be effects on neural 
impulses and resulting influence on brain function. Thus, the addition of 
interactions with the risks of altered immune function and altered microbi-
al physiology and virulence would be useful. Further, the potential for in-
teractions with the risks noted in other evidence reports could be added, 
including  
 
• Risk of Impaired Performance Due to Reduced Muscle Mass, 
Strength, and Endurance (Ploutz-Snyder et al., 2015), 
• Risk of Injury and Compromised Performance Due to EVA Op-
erations (Chappell et al., 2015), 
• Risk of Performance Decrement and Crew Illness Due to an In-
adequate Food System (Perchonok et al., 2012),  
• Risk of Performance and Behavioral Health Decrements Due to 
Inadequate Cooperation, Coordination, Communication, and 
Psychosocial Adaptation Within a Team (Landon et al., 2015).  
 
What Is the Overall Readability and Quality? 
 
The report as written has the character of two separate catalogs (one 
written from the perspective of individual nutrients, one from a body sys-
tems perspective) simply being concatenated, with substantial duplica-
tion across the sections, and lacking narrative that puts into perspective 
the actual (versus theoretical) inflight risks associated with inadequate 
nutrition. While a large list or catalog is useful for knowledgeable re-
searchers as a reference resource, the report in its current form lacks per-
spective and does not serve one of the uses of the evidence reports, 
which is to engage new generations of researchers and students in solv-
ing the health challenges associated with spaceflight. The purpose would 
be served more effectively by a much shorter version of the first section 
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focused on key issues of dietary content, intake, and stability where risks 
of nutritional deficits on human performance are highest. As noted 
above, there is no synthesis of nutrient level data with equally important 
issues of nutrient interactions and diet. In this regard, food groups could 
be broken down into groups of nutrient sources to determine whether 
astronauts can be assured of getting sufficient amounts in long-duration 
missions. 
Statistically significant differences are commonly included in data 
cited in the report, without addressing whether such differences are bio-
logically significant. 
 
Is the Breadth of the Cited Literature Sufficient? 
 
The report contains 1,032 references, which in some areas is exces-
sive. Given the breadth of the literature, the reference list could be re-
vised to include only key references. There were references dated as late 
as 2014 in the later sections of the report that dealt with nutrient effects 
on different aspects of physiology, but stress physiology including oxida-
tive stress and antioxidant impacts were someone dated and missing key 
elements. For example, glutathione along with vitamin C, vitamin E, and 
selenium are the most physiologically-relevant antioxidants but no con-
sideration of glutathione and nutrient precursors was given. 
 
Is the Expertise of the Authors Sufficient to Fully Cover 
the Scope of the Given Risk? 
Is Input from Additional Disciplines Needed? 
 
In a narrow sense, that of classes of nutrients and standard dietary 
requirements, author expertise is clearly sufficient. A more holistic view 
of nutrition and the factors that influence it, particularly for long-duration 
missions, will profit from including expertise in behavioral science and 
contemporary molecular biology that affects human metabolism, espe-
cially in the area of responses to diverse stresses. 
Understanding of the relationship between individual nutrient intake 
and overall individual diet patterns would benefit from contributions by 
behavioral health researchers. Additional input from physiologists and 
biochemists studying the effects of phytochemicals on human metabo-
lism, especially in the inflammatory response, is needed to design diets 
for long-term spaceflight that will confer the benefits that adequate in-
take of fruits and vegetables provide. Certain supplements using extracts 
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of fruits and vegetables in stable forms that could be made into beverages 
or other consumable forms should be considered. 
 
Has the Evidence Report Addressed Previous Recommendations  
Made by the IOM in the 2008 Letter Report? 
 
The 2008 report noted the following challenges with this evidence 
report that have not been addressed to date.  
 
Although the document covers evidence regarding 31 nutrients, 
it does not explain how this list was generated. Therefore it is 
difficult to know whether these 31 factors were selected from a 
larger list or if these are all the possible nutrients that could be 
considered. From the lay perspective, the list would be exhaus-
tive and possibly unnecessary due to the varying levels of 
strength in the arguments for each. This could be partially clari-
fied by including a review of the current nutritional guidelines 
used for astronauts and relevant gaps in knowledge associated 
with each standard. (IOM, 2008, p. 59)  
 
An enormous amount of evidence is reviewed regarding nutrition 
and previous spaceflights, and it seems likely that that infor-
mation could be condensed and summarized. (IOM, 2008, p. 60) 
 
  
SUMMARY 
 
This is the third of five letter reports that will review the entire series 
of NASA’s evidence reports on human health risks. This letter report 
reviewed seven evidence reports and provided the committee’s responses 
to the questions detailed in the statement of task. The evidence reports 
are quite thorough in their review of the evidence of spaceflight risks, 
although they vary in format and in the consistency and quality of the 
writing. In general, the reports would benefit from the perspectives of 
authors from more diverse fields and from adding authors from outside 
of NASA staff and contractors.  
Many of these reports cover broad fields of research, and the com-
mittee appreciates the challenges in identifying and summarizing the 
most salient literature. Challenges also arise in finding the best way to 
highlight the interactions between risks. The reports do an adequate job 
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of discussing the interactions between those risks that are most directly 
related, but they struggle with establishing the connections and interac-
tions among risks that are related, but a bit more tangential (e.g., relation 
of nutrition and food supply to many of the other risks such as muscle 
performance).  
In most of the evidence reports that were reviewed, it was evident 
that the tasks to be accomplished during exploration class missions need 
to be better defined and need to be incorporated in the evidence reports 
so that the nature and extent of the risks can be fully explored. The dis-
tinctions between EVAs performed on aboard the ISS and the EVAs that 
would be performed on planetary surfaces appear to be so significant that 
the committee suggests different terminology be employed. In the EVA 
and DCS reports, the committee notes that only one kind of suit architec-
ture is considered. The committee recommends that the risks be more 
fully explored and the possibility of other types of suit architecture be 
considered. Finally, individual variability (both positive and negative) is 
not adequately addressed (e.g., in the reports on DCS and orthostasis).  
The committee greatly appreciates the opportunity to review the evi-
dence reports and applauds NASA’s commitment to improving the quali-
ty of its reports. The evidence reports provide the basis for the work of 
NASA’s Human Research Program, and the in-depth review that they 
provide will contribute to improving the health and performance of fu-
ture astronauts and enhancing future human spaceflights endeavors.  
 
Sincerely, 
 
Carol E. H. Scott-Conner, Chair 
Daniel R. Masys, Vice Chair 
Committee to Review NASA’s Evidence Reports 
 on Human Health Risks 
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